ECM
ELOS

Endurant Capital Management’s Syneron Medical Ltd ELOS Stock Holding History

Endurant Capital Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-119,545
Closed -$855K – 89
2015
Q3 		$855K Sell
119,545
-210,369
-64% -$2.02M 0.29% 62
2015
Q2 		$3.5M Buy
329,914
+231,114
+234% +$2.71M 1.03% 32
2015
Q1 		$1.22M Buy
+98,800
New +$1.09M 0.4% 65

Other funds holding ELOS

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Endurant Capital Management's ELOS Position: Q4 2015 in Review

Endurant Capital Management sold out of Syneron Medical Ltd (ELOS) in Q4 2015, closing a stake of 119,545 shares — an estimated $855K sold.

Endurant Capital Management first reported a position in ELOS in Q1 2015 and held it in 3 quarters. The position peaked at $3.5M in Q2 2015. 57 funds tracked by Wall St. Rank hold ELOS as of Q4 2015.

  • Endurant Capital Management reported no remaining Syneron Medical Ltd position as of Q4 2015 after selling out during the quarter.
  • Endurant Capital Management sold 119,545 Syneron Medical Ltd shares in Q4 2015, an estimated $855K.
  • Endurant Capital Management first reported a position in Syneron Medical Ltd in Q1 2015 and held it in 3 quarters.
  • Endurant Capital Management's Syneron Medical Ltd position peaked at $3.5M in Q2 2015.
  • 57 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q4 2015.

Based on Endurant Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.